Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pregnancy Registries May Use External Comparison Groups – Final Guidance

Executive Summary

Pregnancy exposure registries may use external comparison groups, including background rates, surveillance systems and other registries, FDA said in its 1pregnancy registry final guidance
Advertisement

Related Content

FDA Poised To Require More Rigorous Study Of Drug Use In Pregnancy
Drug Safety In Pregnant Women: FDA Seeks Alternatives To Registries
FDA “Xes” Letter Categories For Pregnancy Labels; Data Collection Drives Reg
FDA “Xes” Letter Categories For Pregnancy Labels; Data Collection Drives Reg
Pregnancy Registry Guidance Could Stress Collaboration, Tackle HIPAA
Pregnancy Registry Guidance Could Stress Collaboration, Tackle HIPAA
Phase IV Commitments For Registries Likely To Increase, Genentech Says
Phase IV Commitments For Registries Likely To Increase, Genentech Says
Pregnancy Registry Data Use In Labeling Should Be Compiled By FDA - PhRMA
Pregnancy Registry Data Use In Labeling Should Be Compiled By FDA - PhRMA
Advertisement
UsernamePublicRestriction

Register

PS040552

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel